Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.

Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS.

Circulation. 2004 Sep 14;110(11):1492-8. Epub 2004 Sep 7.

2.

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia.

Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1686-91.

3.

Role of the fatty acid binding protein mal1 in obesity and insulin resistance.

Maeda K, Uysal KT, Makowski L, Görgün CZ, Atsumi G, Parker RA, Brüning J, Hertzel AV, Bernlohr DA, Hotamisligil GS.

Diabetes. 2003 Feb;52(2):300-7.

4.

Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice.

Layne MD, Patel A, Chen YH, Rebel VI, Carvajal IM, Pellacani A, Ith B, Zhao D, Schreiber BM, Yet SF, Lee ME, Storch J, Perrella MA.

FASEB J. 2001 Dec;15(14):2733-5. Epub 2001 Oct 15.

PMID:
11606480
5.

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.

Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF.

Nat Med. 2001 Jun;7(6):699-705. doi: 10.1038/89076.

6.

Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice.

Cao H, Maeda K, Gorgun CZ, Kim HJ, Park SY, Shulman GI, Kim JK, Hotamisligil GS.

Diabetes. 2006 Jul;55(7):1915-22.

7.

Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.

Babaev VR, Runner RP, Fan D, Ding L, Zhang Y, Tao H, Erbay E, Görgün CZ, Fazio S, Hotamisligil GS, Linton MF.

Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1283-90. doi: 10.1161/ATVBAHA.111.225839. Epub 2011 Apr 7.

8.

Macrophages, inflammation, and atherosclerosis.

Linton MF, Fazio S.

Int J Obes Relat Metab Disord. 2003 Dec;27 Suppl 3:S35-40. Review.

PMID:
14704742
9.

Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS.

Endocrinology. 2000 Sep;141(9):3388-96.

PMID:
10965911
10.

Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.

Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, Cao Q, Atsumi G, Malone H, Krishnan B, Minokoshi Y, Kahn BB, Parker RA, Hotamisligil GS.

Cell Metab. 2005 Feb;1(2):107-19.

11.

Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice.

Detmers PA, Hernandez M, Mudgett J, Hassing H, Burton C, Mundt S, Chun S, Fletcher D, Card DJ, Lisnock J, Weikel R, Bergstrom JD, Shevell DE, Hermanowski-Vosatka A, Sparrow CP, Chao YS, Rader DJ, Wright SD, Puré E.

J Immunol. 2000 Sep 15;165(6):3430-5.

12.

Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice.

Perrella MA, Pellacani A, Layne MD, Patel A, Zhao D, Schreiber BM, Storch J, Feinberg MW, Hsieh CM, Haber E, Lee ME.

FASEB J. 2001 Aug;15(10):1774-6. No abstract available.

PMID:
11481226
13.

Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.

Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.

Biochem Biophys Res Commun. 2004 Apr 23;317(1):223-9.

PMID:
15047172
14.

Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.

Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M.

Atherosclerosis. 2014 Jan;232(1):40-51. doi: 10.1016/j.atherosclerosis.2013.10.016. Epub 2013 Oct 31.

PMID:
24401215
15.

Paradoxical reduction of atherosclerosis in apoE-deficient mice with obesity-related type 2 diabetes.

Lyngdorf LG, Gregersen S, Daugherty A, Falk E.

Cardiovasc Res. 2003 Oct 1;59(4):854-62.

PMID:
14553825
16.

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM.

Science. 1996 Nov 22;274(5291):1377-9.

PMID:
8910278
17.

Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.

Kawashima Y, Chen J, Sun H, Lann D, Hajjar RJ, Yakar S, Leroith D.

Diabetologia. 2009 Jul;52(7):1434-41. doi: 10.1007/s00125-009-1378-8. Epub 2009 May 13.

18.

Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.

Zhang W, Yancey PG, Su YR, Babaev VR, Zhang Y, Fazio S, Linton MF.

Circulation. 2003 Nov 4;108(18):2258-63. Epub 2003 Oct 27.

19.

Bone marrow chimerism prevents atherosclerosis in arterial walls of mice deficient in apolipoprotein E.

Sakai Y, Kim DK, Iwasa S, Liang J, Watanabe T, Onodera M, Nakauchi H.

Atherosclerosis. 2002 Mar;161(1):27-34.

PMID:
11882314
20.

Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.

Li J, Wang Q, Chai W, Chen MH, Liu Z, Shi W.

Cardiovasc Diabetol. 2011 Dec 28;10:117. doi: 10.1186/1475-2840-10-117.

Supplemental Content

Support Center